87 related articles for article (PubMed ID: 17443844)
21. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
El-Khoury V; Breuzard G; Fourré N; Dufer J
Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
[TBL] [Abstract][Full Text] [Related]
22. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.
Katsura T; Iwai S; Ota Y; Shimizu H; Ikuta K; Yura Y
Cancer Gene Ther; 2009 Mar; 16(3):237-45. PubMed ID: 18949013
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
24. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
[TBL] [Abstract][Full Text] [Related]
25. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A.
Lu MC; Du YC; Chuu JJ; Hwang SL; Hsieh PC; Hung CS; Chang FR; Wu YC
Arch Toxicol; 2009 Feb; 83(2):121-9. PubMed ID: 18709356
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK.
Kim DW; Chae JI; Kim JY; Pak JH; Koo DB; Bahk YY; Seo SB
J Cell Biochem; 2009 Apr; 106(6):1048-59. PubMed ID: 19229864
[TBL] [Abstract][Full Text] [Related]
27. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin.
Svechnikova I; Almqvist PM; Ekström TJ
Int J Oncol; 2008 Apr; 32(4):821-7. PubMed ID: 18360709
[TBL] [Abstract][Full Text] [Related]
28. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
29. Proteomic profiling of human colon cancer cells treated with the histone deacetylase inhibitor belinostat.
Beck HC; Petersen J; Nielsen SJ; Morsczeck C; Jensen PB; Sehested M; Grauslund M
Electrophoresis; 2010 Aug; 31(16):2714-21. PubMed ID: 20717991
[TBL] [Abstract][Full Text] [Related]
30. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
Nawrocki ST; Carew JS; Douglas L; Cleveland JL; Humphreys R; Houghton JA
Cancer Res; 2007 Jul; 67(14):6987-94. PubMed ID: 17638911
[TBL] [Abstract][Full Text] [Related]
32. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
[TBL] [Abstract][Full Text] [Related]
33. In vitro ageing of pig oocytes: effects of the histone deacetylase inhibitor trichostatin A.
Jeseta M; Petr J; Krejcová T; Chmelíková E; Jílek F
Zygote; 2008 May; 16(2):145-52. PubMed ID: 18405435
[TBL] [Abstract][Full Text] [Related]
34. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
[TBL] [Abstract][Full Text] [Related]
35. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
[TBL] [Abstract][Full Text] [Related]
36. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells.
Gensert JM; Baranova OV; Weinstein DE; Ratan RR
Neurobiol Dis; 2007 Jun; 26(3):671-80. PubMed ID: 17481908
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.
Chittur SV; Sangster-Guity N; McCormick PJ
BMC Genomics; 2008 Oct; 9():507. PubMed ID: 18959802
[TBL] [Abstract][Full Text] [Related]
38. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A.
Galiová G; Bártová E; Raska I; Krejcí J; Kozubek S
Eur J Cell Biol; 2008 May; 87(5):291-303. PubMed ID: 18396346
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma.
Hamner JB; Sims TL; Cutshaw A; Dickson PV; Rosati S; McGee M; Ng CY; Davidoff AM
J Pediatr Surg; 2008 Jan; 43(1):177-82; discussion 182-3. PubMed ID: 18206478
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death.
Egler V; Korur S; Failly M; Boulay JL; Imber R; Lino MM; Merlo A
Clin Cancer Res; 2008 May; 14(10):3132-40. PubMed ID: 18483381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]